Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02560584 · ClinicalTrials.gov registry record · Phase 3
A Study of Blue Light Flexible Cystoscopy With Cysview in the Detection of Bladder Cancer in the Surveillance Setting
A Phase 3 study, sponsored by Photocure.
- Completed
- Registry status
- Phase 3
- Development phase
- 304
- Enrollment target
NCT02560584 is a Phase 3 study that has completed, run by Photocure. The registered enrollment target is 304 participants.
The verdict
NCT02560584, a Phase 3 study, has completed, sponsored by Photocure.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 304 participants
- Enrollment target
Study Summary
The purpose of this study is to investigate if blue light cystoscopy with Cysview improves detection of tumors in patients with bladder cancer during surveillance cystoscopy, using the KARL STORZ D-Light C PDD Flexible Videoscope System. Another purpose is to investigate if Cysview and blue light is safe and effective when used repeatedly.
Interventions
- DRUG Hexaminolevulinate hydrochloride
- DEVICE KARL STORZ D-Light C PDD Flexible Videoscope System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 304 participants |
| Start Date | 2015-10-01 |
| Est. Completion | 2017-04-05 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02560584
The ClinicalTrials.gov registry entry for NCT02560584 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 304 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Photocure, which has 11 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Hexaminolevulinate hydrochloride is the first listed.
NCT02560584 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02560584 about?
NCT02560584 is a clinical study titled "A Study of Blue Light Flexible Cystoscopy With Cysview in the Detection of Bladder Cancer in the Surveillance Setting". The purpose of this study is to investigate if blue light cystoscopy with Cysview improves detection of tumors in patients with bladder cancer during surveillance cystoscopy, using the KARL STORZ D-Light C PDD Flexible Videoscope System. Another purpose is to investigate if Cysview and blue light is...
What is the current status of trial NCT02560584?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 304 participants. The study started on 2015-10-01. Estimated completion is 2017-04-05.
What interventions are being tested in trial NCT02560584?
The interventions under investigation include: Hexaminolevulinate hydrochloride (DRUG), KARL STORZ D-Light C PDD Flexible Videoscope System (DEVICE).
Who is sponsoring clinical trial NCT02560584?
This trial is sponsored by Photocure, which has 11 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.